← Eichor
Study identifier: NCT06513780 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Study of the Correlation Between Portal Vein Thrombosis and Prognosis of Liver Transplantation

Condition: Portal Vein Thrombosis  ·  Sponsor: Ru-zhou Cai

PhaseN/A
Planned participants700
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this observational study is to investigate the correlation between portal vein thrombosis (PVT) and the prognosis of liver transplantation. The main questions it aims to address are: What is the prevalence of PVT? What are the risk factors associated with PVT? What is the prognostic impact of preoperative PVT on liver transplantation? Participants are divided into two groups: the PVT group and the non-PVT group. The investigators will comparatively analyze the data of both groups, estimate the prevalence and risk factors of PVT, construct a predictive model for PVT that is applicable in clinical settings, and clarify the prognostic effects of PVT.

This description comes directly from the study's public registry record.

Talk to the study team

Ru-zhou Cai, M.D.  ·  18722563616  ·  18722563616@126.com

Always discuss trial participation with your own doctor first.

Locations (1)

Beijing Friendship Hospital, Capital Medical UniversityBeijing, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06513780